anti-interleukin-5 receptor monoclonal antibody
GPTKB entity
Statements (12)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:monoclonal_antibody
|
| gptkbp:administeredBy |
injection
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:example |
gptkb:benralizumab
|
| https://www.w3.org/2000/01/rdf-schema#label |
anti-interleukin-5 receptor monoclonal antibody
|
| gptkbp:mechanismOfAction |
blocks interleukin-5 receptor alpha
|
| gptkbp:reduces |
eosinophil levels
|
| gptkbp:target |
gptkb:interleukin-5_receptor
|
| gptkbp:usedFor |
treatment of eosinophilic asthma
treatment of hypereosinophilic syndrome |
| gptkbp:bfsParent |
gptkb:benralizumab
|
| gptkbp:bfsLayer |
7
|